In June last year, hedge fund manager Falcon Edge Capital told clients about an exciting new investment opportunity that had “virtually zero-risk,” The Financial Times reports. The New York-based firm was referring to SPACs, which have taken Wall Street by storm and become a favourite investment among hedge fund managers. Blank-check companies, Falcon Edge wrote to investors, have an “inherently investor-friendly structure” with little downside. “The key to the SPAC structure is that investors can opt to receive all of their investment back,” it said. Falcon Edge was not the only evangelist. Its letter outlined the reasons why some of the world’s most influential hedge funds have piled into SPACs, fuelling a boom that has proved lucrative for both their early investors and promoters. Read more.
Related Posts
Jim Cramer’s 10 SPACs ‘To Die For’
On a recent “Mad Money” show, he recommended that investors watch for some high-quality SPACs that are trading down with the entire SPAC industry.
FoxWayne, Aerami Therapeutics SPAC Deal Worth $195M: Report
The SPAC executed a non-binding letter of intent with Aerami earlier this month, according to a securities filing.
With no Merger Deal, Failed SPAC Faces Lawsuit Over Legal Fees
New York-founded White & Case sued former client Colonnade Acquisition II and its directors in New York state court late Monday, arguing the firm will be "irreparably harmed" if the blank-check company liquidates and dissolves before paying the fees it owes.
Trump Deal Partner’s Blank-Check Firm Seeks to Avoid Liquidation
The chief executive of the blank-check acquisition firm that plans to merge with former U.S. President Donald Trump’s new social media venture is chasing retail investors to save another of his deals from falling apart